American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,725 | -68,491 | 14,059 | 41,302 | 47,087 |
| Depreciation Amortization | 12,721 | 13,384 | 13,633 | 13,367 | 10,345 |
| Income taxes - deferred | 754 | -5,855 | -403 | -978 | 1,206 |
| Accounts receivable | -6,823 | 12,786 | -25,708 | -20,112 | -14,542 |
| Accounts payable and accrued liabilities | -6,368 | 4,124 | 2,017 | -4,791 | 4,855 |
| Other Working Capital | -7,168 | 12,186 | -23,386 | -27,027 | 610 |
| Other Operating Activity | 20,157 | 61,821 | 27,999 | 25,806 | 25,249 |
| Operating Cash Flow | $-46,453 | $29,956 | $8,212 | $27,568 | $74,810 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18,663 | -36,396 | -6,063 | -3,886 | -73,127 |
| Net Acquisitions | N/A | 615 | N/A | N/A | -53,056 |
| Purchase Of Investment | 18,329 | 5,160 | -54 | -239 | -22,380 |
| Purchase Sale Intangibles | -3,970 | N/A | -18 | -1,119 | -99,547 |
| Other Investing Activity | 15,516 | -41,327 | -224 | -2,631 | -108,812 |
| Investing Cash Flow | $15,182 | $-71,949 | $-6,341 | $-6,756 | $-257,374 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 18,914 | N/A | 6,765 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 119,839 |
| Debt Repayment | -18,479 | -3,160 | N/A | N/A | -11,468 |
| Common Stock Repurchased | -1,271 | -800 | N/A | N/A | N/A |
| Other Financing Activity | -14,650 | -302 | -10,635 | 1,807 | -29,999 |
| Financing Cash Flow | $-15,486 | $-4,262 | $-3,870 | $1,807 | $78,372 |
| Exchange Rate Effect | 1,227 | 4,314 | 5,442 | 447 | 5,843 |
| Beginning Cash Position | 52,628 | 94,569 | 91,127 | 68,061 | 166,410 |
| End Cash Position | 7,097 | 52,628 | 94,569 | 91,127 | 68,061 |
| Net Cash Flow | $-45,531 | $-41,941 | $3,442 | $23,066 | $-98,349 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,453 | 29,956 | 8,212 | 27,568 | 74,810 |
| Capital Expenditure | -18,663 | -36,396 | -6,063 | -3,980 | -73,136 |
| Free Cash Flow | -65,117 | -6,440 | 2,148 | 23,588 | 1,674 |